Alabama Senate Bill SB182

Alabama 2025 Regular Session

• Introduced: 2/20/25
• Refer: 2/20/25

Caption

Psychoactive cannabinoids; prohibit sale of beverages containing psychoactive cannabinoids; criminal penalties provided

Impact

If enacted, SB182 will have significant implications for businesses that manufacture or sell cannabinoid-infused beverages. The prohibition on selling these products will likely lead to a reduction in the availability of such beverages in the market, effectively curtailing a growing sector of the cannabis economy in Alabama. Businesses wholesale or retailing these items will need to adjust their practices to comply with the new restrictions, which could result in increased operational costs and potential losses.

Summary

SB182 seeks to amend existing laws regarding psychoactive cannabinoids in the state of Alabama. The bill specifically prohibits the sale of beverages containing any psychoactive cannabinoid derivatives, such as delta-8 THC, delta-9 THC, and delta-10 THC, with certain exceptions provided under medical cannabis laws. The bill aims to protect minors by restricting access to these products and ensuring that such items are not sold or marketed to individuals under the age of 21. Furthermore, all psychoactive cannabinoids must be stored in locations where minors cannot gain access.

Contention

The bill may face challenges from stakeholders in the cannabis industry who argue that such prohibitions could hinder the market's growth and negatively impact businesses that thrive on the sale of cannabinoid products. Advocates for public health and safety may support the bill, arguing it is essential for protecting minors from potentially harmful substances; however, opposing views might express concerns about the potential for overreach, impacting responsible adult consumption. Additionally, the inclusion of criminal penalties for violations—such as Class B misdemeanors for selling these beverages—could spark debates about appropriate regulatory measures.